Formulation of intranasal mucoadhesive temperature-mediatedin situgel containing ropinirole and evaluation of brain targeting efficiency in rats
- 23 December 2009
- journal article
- research article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 18 (3) , 223-234
Abstract
Mucoadhesive temperature-mediated in situ gel formulations using chitosan and hydroxyl propyl methyl cellulose were used to enhance intranasal (i.n.) delivery of the dopamine D2 agonist ropinirole to the brain. Formulations were tested for gelation time, thermosensitivity, mucoadhesion, in vitro release and permeation, in vitro cytotoxicity, nasal clearance, in vivo bioavailability and brain uptake. In vivo bioavailability and brain uptake of ropinirole were assessed in albino rats following intranasal administration of 99mTc-ropinirole in situ gel, intranasal ropinirole solution and intravenous (i.v.) ropinirole solution. Radiolabeled ropinirole uptake was calculated as a fraction of administered dose. The absolute bioavailabilty of ropinirole from the temperature-mediated in situ gelling nasal formulation was 82%. The AUC 0–480 min in brain after nasal administration of ropinirole in situ gel was 8.5 times (869 ± 250% · min/g versus 102 ± 20% · min/g) that obtained following i.v. administration, this value was also considerably higher (869 ± 250% · min/g versus 281 ± 52% · min/g) than that achieved with intranasal ropinirole solution. High brain direct drug transport percentage (DTP; 90.36%) and drug targeting index (DTI) > 1 confirms direct nose to brain transport of the intranasal in situ gel formulation of ropinirole.Keywords
This publication has 40 references indexed in Scilit:
- Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat ModelPharmaceutical Research, 2008
- Nasal administration of an angiotensin antagonist in the rat model: Effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systemsInternational Journal of Pharmaceutics, 2007
- Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: In vitro characterisation studiesJournal of Controlled Release, 2007
- Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applicationsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailabilityInternational Journal of Pharmaceutics, 2003
- Evaluation of 99mTc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphyNuclear Medicine and Biology, 2000
- Evaluation of starch–maltodextrin–Carbopol® 974 P mixtures for the nasal delivery of insulin in rabbitsJournal of Controlled Release, 2000
- Mucoadhesive Drug Delivery SystemsDrug Development and Industrial Pharmacy, 1997
- The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitroJournal of Controlled Release, 1996
- Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)Pharmaceutical Research, 1994